
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
DRUGS IN DEVELOPMENTEntry Inhibitors:
15D, Preclinical, National Cancer Institute
15K, Preclinical, National Cancer Institute
Alpha defensins, Preclinical, CDC's AIDS, STD, and TB Laboratory Research
AMD887 (CCR5 blocker), Preclinical, Anormed
AMD3451 (CCR5-CXCR4 blocker), Preclinical, Anormed
Aprepitant (NK-1R blocker), Preclinical, University of Pennsylvania
Betulinic acid derivatives, Preclinical, University of North Carolina, Duke University, Vanderbilt University
Bifunctional CCR5 and CD4 inhibitors, Preclinical, University of Regensburg
CCR5mAb004 (CCR5 blocker), Phase I, Human Genome Sciences
D5 (monoclonal antibody), Preclinical, Merck
DP-178 (fusion inhibitor), Preclinical, Weizmann Institute
GBV-C (chemokines, including CCR5 blockers), Preclinical, University of Iowa
Genistein, Preclinical, Uniformed Services University of Health Sciences
gp41 inhibitor, Preclinical, New York Blood Center
gp41 inhibitor, Preclinical, Locus Pharmaceuticals
gp120-gp41 disulfide bond, Preclinical, Amsterdam Mathematical Center, Cornell University, University of Illinois at Chicago
HGS004 (CCR5 blocker, Phase I/II, Human Genome Sciences
HGS101 (CCR5 blocker), Preclinical, Human Genome Sciences
IC9564, Preclinical, Duke University
INCB9471 (CCR5 blocker), Phase I/II, Incyte
INCB15050, Preclinical, Incyte
Indolicidin, Preclinical, National Institutes of Health
KD-247 (CCR5 blocker), Preclinical, Kumamoto University
KRH-3140 (CXCR4 blocker), Preclinical, Kureha
KRH-3955 (CXCR4 blocker), Preclinical, Kureha
MDX-010, Preclinical, Medarex
Monoclonal FAbs (gp41 blocker), Preclinical, National Institutes of Health
NB-2 (gp41 blocker), Preclinical, Shibo and Kumar
NB-64 (gp41 blocker), Preclinical, Shibo and Kumar
NSC 13778 (gp120 blocker), Preclinical, National Cancer Institute
Peptidic CCR5 blocker, Preclinical, Selexis
PF232798 (CCR5 blocker), Phase I, Pfizer
PRO-140 (monoclonal antibody), Phase I/II, Progenics
Pyrrolidine (CCR5 blocker), Preclinical, Merck
RC-112, Preclinical, CDC's AIDS, STD, and TB Laboratory Research
Retrocyclin-1, Preclinical, CDC's AIDS, STD, and TB Laboratory Research
ROAb 12 (CCR5 blocker), Preclinical, Roche
ROAb 13 (CCR5 blocker), Preclinical, Roche
ROAb 14 (CCR5 blocker), Preclinical, Roche
ROAb 18 (CCR5 blocker), Preclinical, Roche
SCH-5327-6 (CCR5 blocker), Preclinical, Schering-Plough
Sifuvirtide, Preclinical, Fusogen
SP10A (entry inhibitor), Preclinical, Samaritan
Suc-HSA (gp120 blocker), Phase I, Sanquin
TAK-220 (CCR5 blocker), Phase 1, Tobira (licensed from Takeda)
TAK-652 (CCR5 blocker), Phase I, Tobira (licensed from Takeda)
TD0232, Preclinical, Avexa
TNX-355 (monoclonal antibody), Phase II, Tanox and Biogen
TR-999, Preclinical, Trimeris and Roche
TR-1144, Preclinical, Trimeris and Roche
UMIST, Preclinical, Genetic Innovation Network
Vicriviroc (CCR5 blocker), Phase II, Schering-Plough
ZFN (CCR5 blocker), Preclinical, Sangamo Biosciences
Zing finger protein nucleases (CCR5 blockers), Preclinical, Sangamo Biosciences
Integrase Inhibitors:
AVX-I, Preclinical, Avexa
Beta-diketo acids, Preclinical, University of Parma and University of Sassari
Carbazole derivative, Preclinical, Japan's National Institute of Infectious Diseases
Elvitegravir (GS-9137), Phase II, Gilead Sciences
GS-9224, Preclinical, Gilead Sciences
GSK-810871, Preclinical, GlaxoSmithKline
GSK364735, Phase I, GlaxoSmithKline/Shionogi
ITI-367, Preclinical, George Washington University
L-second generation, Preclinical, Merck
Monophores, Preclinical, Sunesis
Mycelium integrasone fungal polyketide, Preclinical, Merck
PL-2500, Preclinical, Procyon Biopharma
Styrylquinoline derivatives, Preclinical, BioAlliance Pharma
Theophylline, Preclinical, Thomas Jefferson University
V-165, Preclinical, Rega Institute
Maturation Inhibitors:
Betulinic acid derivatives, Preclinical, University of North Carolina, Duke University, Vanderbilt University
Bevirimat (PA-457) (gag processing inhibitor), Phase II, Panacos
Capsid inhibitors, Preclinical, Achillion
enJS56A1, (endogenous antiretroviral, Preclinical, University of Georgia
PA1050040, (gag processing inhibitor), Phase 1, Panacos
RPI-MN, (nAchR receptor inhibitor), Preclinical, ReceptoPharm
Nonnucleoside Reverse Transcriptase Inhibitors:
70h (GW678248), Phase I, GlaxoSmithKline
AR806, Preclinical, Ardea Biosciences
BILR 355/r BS, Phase I/II, Boehringer Ingelheim
C-8 quinolinyloxyethyl substitutent, Preclinical, Boehringer Ingelheim
HBY097 (Pyridinone derivatives), Preclinical, Rutgers University
Methyl derivatives, Preclinical, University of South Denmark
MV026048, Preclinical, Medivir
Oligodeoxinucleotides, Preclinical, University of Zurich
PBO-15c (pyrrolobenzoxazepinone), Preclinical, University of Siena
Phenylthiazoylamines, Preclinical, Yale University
Rilpivirine (TMC-278), Phase II, Tibotec
S-DABO derivatives, Preclinical, Fudan University
SMP-610, Preclinical, Advanced Life Sciences
SMP-717, Preclinical, Advanced Life Sciences
Thiazol derivatives, Preclinical, Japan's Institute for Virus Research
UK-435061, Phase I/II, Pfizer
Nucleoside Reverse Transcriptase Inhibitors:
4-Ed4T, Preclinical, Kagoshima University
Apricitabine (ATC), Phase I/II, Avexa
ARC, Preclinical, Howard University
BPH-218, Preclinical, University of Pittsburgh
Branched 3 primers, Preclinical, University of Illinois
Compound X, Preclinical, Tibotec
D-FDOC, Preclinical, Emory University
Didox ribonucleotide reductase inhibitor, Preclinical, University of Texas
Dinucleoside polyphosphates, Preclinical, University of Miami
DOT (dioxolane thymidine), Phase I, University of Georgia
dTTP, Preclinical, University of Rochester
E2-FdA, Preclinical, Kumamoto University
Elvucitabine (ACH-126), Phase I/II, Achillion
Fosalvudine (alovudine prodrug), Phase I/II, Heidelberg Pharmaceuticals
GS-9131, Preclinical, Gilead Sciences
Herpesvirus saimiri, Preclinical, Temple University
IDX12899, Preclinical, Idenix Pharmaceuticals
IDX12989, Preclinical, Idenix Pharmaceuticals
KMMP05, Preclinical, National Cancer Institute
Quinolones, Preclinical, Rega Institute
R12-2, Preclinical, University of Texas
Racivir, Phase I/II, Pharmasset
Stampidine, Preclinical, Parker Hughes Institute
Thiostavudine, Preclinical, Showa University
Thiovir, Preclinical, Adventrx
Triol, Preclinical, Cruz Foundation
TSAO-T derivatives, Preclinical, University of Pittsburgh
Protease Inhibitors
A-681799, Preclinical, Abbott Laboratories
Beta-lactam, Preclinical, University of Debrecen
GRL-02031, Preclinical, Kumamoto University
PPL-100, Phase I, Merck
SPI-256, Preclinical, Sequoia
SPI-452, Phase 1, Sequoia Pharmaceuticals
UIC02031, Preclinical, Kumamoto University
Other Classes:
1H4 (tat inhibitor), Preclinical, Taras Shevchenko University
Alpha-V integrins, Preclinical, Merck
BI-201 (tat inhibitor), Phase I, BioInvent
BIT225 (Vpu ion blockers), Phase 1, Biotron Limited
CNI-1493 (rev inhibitor), Preclinical, Optokine Pharmasciences
Curcumin/diferuloylmethane (tat inhibitor), Preclinical, Jawaharlal Nehru Center
Glycodendrimers (lipid raft carbohydrates), Preclinical, Penn State University
Histone deacetylase inhibitors, Preclinical, University of California, San Francisco
HRG214 (caprine IgG), Preclinical, Vironyx
IM (CDK9 inhibitor), Preclinical, Institute of Human Virology
KP-1461 (viral decay accelerator), Phase I/II, Koronis
KU-55933 (ATM kinase inhibitor), Preclinical, Kudos Pharma
LEDGF (integrase competers), Preclinical, Catholic University of Leuven
MDI-P (electrolyzed free radical), Preclinical, Medical Discoveries
Morpholino antisense oligonucleotides, Preclinical, AVI BioPharma
Oxadiazols (nuclear localization viral matrix blockers), Preclinical, International Therapeutics
Poly acrylic acid, Preclinical, Chinese Academy of Science
Resveretol (Egr1 gene activator), Preclinical, National Cancer Institute
Rev inhibitors, Preclinical, National Institutes of Health
RPI (nicotinic acetylcholine receptor blocker), Preclinical, NutraPharma
RSC-1838, Preclinical, GlaxoSmithKline and Shionogi
RWJ67567 (p38 inhibitor), Preclinical, University of Pennsylvania
SCY-635 (cyclophilin inhibitor), Preclinical, Scynexis
siRNA constructs (rev/tat inhibitors), Preclinical, Beckman Institute
siRNA, Preclinical, CombiMatrix
TRIM5-alpha (capsid inhibitor), Preclinical, Dana-Farber Cancer Institute and the National Institute of Allergy and Infectious Diseases
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Plus: Featured Video
Latest Stories
Dancer. Healer. Survivor. DéShaun Armbrister is all of the above
July 02 2025 8:23 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
BREAKING: Supreme Court rules to save free access to preventive care, including PrEP
June 27 2025 10:32 AM
1985: the year the AIDS crisis finally broke through the silence
June 26 2025 11:24 AM
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
VIDEO: A man living with HIV discusses his journey to fatherhood
June 10 2025 4:58 PM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM